Orthopeptide Biotechnology, LLC

Orthopeptide Biotechnology, LLC (OB) is a New Orleans-based life sciences company specializing in the rational design and production of bioactive peptides. OB’s portfolio includes peptides designed to address various inflammatory diseases, especially inflammatory diseases of the kidney and nervous system. The peptide drugs protect against cellular damage and are applicable to a wide range of diseases.


